Millennium Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Millennium Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,700	Closed	-$4.4M	–	6326
2024 Q2	$4.4M	Buy	15,700 +14,800	+1,644%	+$3.52M	﹤0.01%	2843
2024 Q1	$240K	Sell	900 -600	-40%	-$141K	﹤0.01%	5271
2023 Q4	$347K	Sell	1,500 -8,200	-85%	-$1.43M	﹤0.01%	4883
2023 Q3	$1.42M	Buy	9,700 +7,800	+411%	+$1.47M	﹤0.01%	3896
2023 Q2	$439K	Sell	1,900 -15,700	-89%	-$4.25M	﹤0.01%	4633
2023 Q1	$4.26M	Sell	17,600 -37,700	-68%	-$10.3M	﹤0.01%	2753
2022 Q4	$16.1M	Buy	+55,300	New	+$5.41M	0.01%	1648
2019 Q1	–	Sell	-12,500	Closed	-$1.41M	–	4178
2018 Q4	$1.41M	Hold	12,500	–	–	﹤0.01%	2413
2018 Q3	$2.68M	Buy	+12,500	New	+$3.14M	﹤0.01%	2224

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's MDGL Position: Q1 2026 in Review

Millennium Management increased its Madrigal Pharmaceuticals (MDGL) stake by 485% in Q1 2026, buying an estimated $16.2M and bringing the position to 40,853 shares worth $21.4M. The position accounts for 0.01% of the portfolio, ranked #1493.

Millennium Management first reported a position in MDGL in Q2 2013 and has held it in 39 quarters since. The position peaked at $29.1M in Q1 2023. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

Millennium Management held 40,853 shares of Madrigal Pharmaceuticals worth $21.4M as of Q1 2026.
Millennium Management bought 33,875 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $16.2M.
Madrigal Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1493 holding.
Millennium Management first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
Millennium Management's Madrigal Pharmaceuticals position peaked at $29.1M in Q1 2023.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.